Articolul precedent |
Articolul urmator |
361 7 |
Ultima descărcare din IBN: 2024-03-06 23:57 |
SM ISO690:2012 NEVIN, Varghese, LEVINSKY, Sarit, SADOVICI-BOBEICA, Victoria. Reactive arthritis post COVID-19 infection. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 125. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | ||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | ||||||
|
||||||
Pag. 125-125 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Coronavirus disease infection (COVID-19) results in a variety of clinical manifestations and various post-COVID-19 sequelae, which are still under investigation due to the novelty of the disease. Several cases of reactive arthritis (ReA) after COVID-19 infections have been reported since August 2020. Objective of the study. To perform a literature synthesis about the clinical presentation of reactive arthritis after COVID-19 infection. Material and Methods. We have performed a database search of all relevant literature published until May 2021. The search included English written articles. Electronic databases including PubMed, Oxford Academics, Google Scholar were searched using the following terms: “COVID-19 + reactive arthritis”, “SARS-COV-2 + reactive arthritis”, “Coronavirus +reactive arthritis”. Results. 50 articles were selected and 18 sources were considered relevant, published from August 2020 until April 2021, all of these case reports, including 19 patients. The onset of ReA varied from 3 days to 3 months after infection. Although ReA causes asymmetric oligo arthritis in lower limbs, forms of upper limb arthritis, acute monoarthritis or axial involvement can also occur. ReA associated with cutaneous vasculitis and psoriatic lesions were reported. Other manifestations included inflammatory back pain, dactylitis, enthesitis, tendinitis and bursitis. There are no specific laboratory tests for ReA, diagnosis relies on the typical clinical presentation with detection of the trigger .Conclusion. Clinical presentation of post COVID-19 ReA included oligo articular asymmetric arthritis, accompanied by peri-articular involvement (enthesitis, tendinitis) and axial involvement. Observational studies of COVID-19 patients might provide an answer to the incidence of ReA and its prognosis. |
||||||
Cuvinte-cheie COVID-19, reactive arthritis, COVID-19, artrita reactivă |
||||||
|